Cargando…
Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.
Objectives: Acthar Gel is a long-acting formulation of adrenocorticotropic hormone (ACTH) with anti-inflammatory effects thought to be mediated in part through melanocortin receptor activation. This study was initiated to understand the role of Acthar Gel in SLE treatment in rheumatology practices....
Autores principales: | Li, Xiao, Golubovsky, Josh, Hui-Yuen, Joyce, Shah, Ummara, Olech, Ewa, Lomeo, Rosalia, Singh, Vijay, Busch, Howard, Strandberg, Mary Jane, Strandberg, Kayla, Horowitz, Leslie, Askanase, Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850873/ https://www.ncbi.nlm.nih.gov/pubmed/27158444 http://dx.doi.org/10.12688/f1000research.7192.2 |
Ejemplares similares
-
Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus
por: Kapoor, Teja, et al.
Publicado: (2020) -
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2022) -
Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019) -
Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity
por: Askanase, Anca D., et al.
Publicado: (2019) -
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2021)